Jeffrey Silber
Förmögenhet: 579 662 $ per 2026-07-31
Förmögenhet: 579 662 $ per 2026-07-31
Jeffrey Silber is Chief Medical Officer at Ironwood Pharmaceuticals, Inc. since 2026.
Dr. Silber was Chief Medical Officer at Vedanta Biosciences, Inc. from 2020 to 2026.
Dr. Silber completed undergraduate studies at Harvard University and earned a doctorate from Albert Einstein College of Medicine, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-20 | 137 036 ( 0,08 % ) | 579 662 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-07-20 |
| Företag | Position | Slut |
|---|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Teknisk/Vetenskaplig/F&U Direktör | 2026-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån